Abstract

    Open Access Research Article Article ID: AADC-1-101

    Amisulpride in Refractory Behavioral and Psychological Symptoms of Dementia

    Vikas Dhikav*, Dolly Prajapati, Wasifa Muzaffar, Nidhi Agarwal, Sekh Raisuddin, Kuljeet Singh Anand

    Background: Amisulpiride is an atypical antipsychotic used extensively in Schizophrenia and related disorders. The current study explored the safety and tolerability of amisulpride in refractory patients with behavioral and psychological symptoms of dementia (BPSD), especially in agitation and/or aggression.

    Method: A 12-weeks observational study was conducted in Northern India. A Total of 39 subjects with dementias receiving antipsychotics divided into 3 groups: 19 patients on amisulpride, 10 patients on other anti-psychotics (olanzapine, quietiapine and risperidone), 10 patients not on any anti-psychotics. A total of 10 healthy volunteers were taken as controls (n=49). The effectiveness of the antipsychotics in BPSD was evaluated by caregiver rated Likert scale. Agitated Behavior Scale (ABS) was used for categorization of nature of BPSD. Safety and tolerability was assessed using Naranjo Adverse Drug Reaction Probability Scale.

    Results: A total of 39 subjects [M: F=29: 10] with mean age 70±8.1 years, and with mean duration of illness 4.2±2.5 years were recruited. The Mini Mental State Examination (MMSE) was 9.13±8.5. A comparison of ABS scores using Analysis of Variance (ANOVA) showed all groups were statistically different (p<0.0001). The Agitated Behavior Scale Scores (ABS scores) were significantly different when groups on antipsychotics were compared with the BPSD patients not on antipsychotic (p<0.001). ABS scores comparisions using paired t-test showed that the amisulpride group was significantly different before and after the amisulpride treatment (p<0.0001). ABS scores and MMSE had a statistically significant correlation (Pearson correlation coefficient=0.41).

    Conclusions: Amisulpride 100mg/day was safe and well tolerated in patients with refractory BPSD especially in patients with aggression and/or agitation. The tolerability was equivalent to other antipsychotics used routinely in BPSD variety. The self-rated caregiver rating of antipsychotic effectiveness using Likert scale showed the amisulpride had a comparable effectiveness with that of other antipsychotics used routinely in dementias with BPSD.

    Keywords: Amisulpride; Effectiveness; Antipsychotics; Safety; Tolerability; BPSD

    Published on: Jan 3, 2017 Pages: 1-6

    Full Text PDF Full Text HTML DOI: 10.17352/aadc.000001
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Case Reports

    Pinterest on AADC